Skip to main content
. 2022 Feb 23;12(3):354. doi: 10.3390/biom12030354

Figure 2.

Figure 2

(A) SS Groups, log10 scaled 2-D plots for C4, C5, C16, and C18:2 level distributions. (B) Bar plots with the respective medians for each of the important acylcarnitines for the SS groups. (C) Log10 scaled grouped box plots with the respective medians for the C4/C18:2 carnitine ratio in each of the CAD groups for all three SS groups. (D) Linear relationship of the C4/C18:2 ratio to the continuous SS as identified by the linear regression model presented in text. (E) ROC analysis of the C4/C18:2 ratio for high risk SS Group > 22.